Clinical Trial

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Recruiting
View on ClinicalTrials.gov →
Summary
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-07; most recent amendment 2025-07-18.
Status change: Not Yet Recruiting → Recruiting 2025-07-18
Trial Details
NCT Number NCT06681818
Lead Sponsor Englewood Hospital and Medical Center
Conditions Liver Cancer Adult, Liver Regeneration
Enrollment 125 participants
Start Date 2025-11-21
Primary Completion 2039-01-01 (estimated)
Study Completion 2039-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-23